221 related articles for article (PubMed ID: 7499324)
21. Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states.
Swaminath G; Xiang Y; Lee TW; Steenhuis J; Parnot C; Kobilka BK
J Biol Chem; 2004 Jan; 279(1):686-91. PubMed ID: 14559905
[TBL] [Abstract][Full Text] [Related]
22. Structural and functional roles of small group-conserved amino acids present on helix-H7 in the β(2)-adrenergic receptor.
Arakawa M; Chakraborty R; Upadhyaya J; Eilers M; Reeves PJ; Smith SO; Chelikani P
Biochim Biophys Acta; 2011 Apr; 1808(4):1170-8. PubMed ID: 21262196
[TBL] [Abstract][Full Text] [Related]
23. Binding of purified recombinant beta-arrestin to guanine-nucleotide-binding-protein-coupled receptors.
Söhlemann P; Hekman M; Puzicha M; Buchen C; Lohse MJ
Eur J Biochem; 1995 Sep; 232(2):464-72. PubMed ID: 7556195
[TBL] [Abstract][Full Text] [Related]
24. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.
DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK
Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234
[TBL] [Abstract][Full Text] [Related]
25. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.
Staus DP; Strachan RT; Manglik A; Pani B; Kahsai AW; Kim TH; Wingler LM; Ahn S; Chatterjee A; Masoudi A; Kruse AC; Pardon E; Steyaert J; Weis WI; Prosser RS; Kobilka BK; Costa T; Lefkowitz RJ
Nature; 2016 Jul; 535(7612):448-52. PubMed ID: 27409812
[TBL] [Abstract][Full Text] [Related]
26. A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration.
Barak LS; Tiberi M; Freedman NJ; Kwatra MM; Lefkowitz RJ; Caron MG
J Biol Chem; 1994 Jan; 269(4):2790-5. PubMed ID: 7507928
[TBL] [Abstract][Full Text] [Related]
27. Real-time analysis of ternary complex on particles: direct evidence for partial agonism at the agonist-receptor-G protein complex assembly step of signal transduction.
Simons PC; Biggs SM; Waller A; Foutz T; Cimino DF; Guo Q; Neubig RR; Tang WJ; Prossnitz ER; Sklar LA
J Biol Chem; 2004 Apr; 279(14):13514-21. PubMed ID: 14726530
[TBL] [Abstract][Full Text] [Related]
28. Activation of the beta(2)-adrenergic receptor-Galpha(s) complex leads to rapid depalmitoylation and inhibition of repalmitoylation of both the receptor and Galpha(s).
Loisel TP; Ansanay H; Adam L; Marullo S; Seifert R; Lagacé M; Bouvier M
J Biol Chem; 1999 Oct; 274(43):31014-9. PubMed ID: 10521499
[TBL] [Abstract][Full Text] [Related]
29. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
[TBL] [Abstract][Full Text] [Related]
30. Plasmon-waveguide resonance studies of ligand binding to the human beta 2-adrenergic receptor.
Devanathan S; Yao Z; Salamon Z; Kobilka B; Tollin G
Biochemistry; 2004 Mar; 43(11):3280-8. PubMed ID: 15023079
[TBL] [Abstract][Full Text] [Related]
31. Beta 1-adrenergic and dopamine (D1)-receptors coupled to adenylyl cyclase activation in GT1 gonadotropin-releasing hormone neurosecretory cells.
Findell PR; Wong KH; Jackman JK; Daniels DV
Endocrinology; 1993 Feb; 132(2):682-8. PubMed ID: 8093877
[TBL] [Abstract][Full Text] [Related]
32. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis].
Shpakov AO; Derkach KV; Uspenskaia ZI; Shpakova EA; Kuznetsova LA; Plesneva SA; Pertseva MN
Tsitologiia; 2004; 46(4):317-25. PubMed ID: 15346790
[TBL] [Abstract][Full Text] [Related]
33. Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies.
Granier S; Kim S; Shafer AM; Ratnala VR; Fung JJ; Zare RN; Kobilka B
J Biol Chem; 2007 May; 282(18):13895-905. PubMed ID: 17347144
[TBL] [Abstract][Full Text] [Related]
34. A truncation mutation in the avian beta-adrenergic receptor causes agonist-induced internalization and GTP-sensitive agonist binding characteristic of mammalian receptors.
Hertel C; Nunnally MH; Wong SK; Murphy EA; Ross EM; Perkins JP
J Biol Chem; 1990 Oct; 265(29):17988-94. PubMed ID: 1976632
[TBL] [Abstract][Full Text] [Related]
35. Fluorogen activating proteins in flow cytometry for the study of surface molecules and receptors.
Saunders MJ; Szent-Gyorgyi C; Fisher GW; Jarvik JW; Bruchez MP; Waggoner AS
Methods; 2012 Jul; 57(3):308-17. PubMed ID: 22366230
[TBL] [Abstract][Full Text] [Related]
36. Repetitive endocytosis and recycling of the beta 2-adrenergic receptor during agonist-induced steady state redistribution.
Morrison KJ; Moore RH; Carsrud ND; Trial J; Millman EE; Tuvim M; Clark RB; Barber R; Dickey BF; Knoll BJ
Mol Pharmacol; 1996 Sep; 50(3):692-9. PubMed ID: 8794912
[TBL] [Abstract][Full Text] [Related]
37. Mutated human beta3-adrenergic receptor (Trp64Arg) lowers the response to beta3-adrenergic agonists in transfected 3T3-L1 preadipocytes.
Kimura K; Sasaki N; Asano A; Mizukami J; Kayahashi S; Kawada T; Fushiki T; Morimatsu M; Yoshida T; Saito M
Horm Metab Res; 2000 Mar; 32(3):91-6. PubMed ID: 10786926
[TBL] [Abstract][Full Text] [Related]
38. Ligand stabilization of the beta 2 adrenergic receptor: effect of DTT on receptor conformation monitored by circular dichroism and fluorescence spectroscopy.
Lin S; Gether U; Kobilka BK
Biochemistry; 1996 Nov; 35(46):14445-51. PubMed ID: 8931540
[TBL] [Abstract][Full Text] [Related]
39. A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism.
Shore JD; Day DE; Francis-Chmura AM; Verhamme I; Kvassman J; Lawrence DA; Ginsburg D
J Biol Chem; 1995 Mar; 270(10):5395-8. PubMed ID: 7890653
[TBL] [Abstract][Full Text] [Related]
40. Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine.
Weitl N; Seifert R
J Pharmacol Exp Ther; 2008 Dec; 327(3):760-9. PubMed ID: 18772317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
